Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples